• Interventions in Ocular Surgery: Reducing Ocular Infection and Inflammation
  • CME

  • Interventions in Ocular Surgery: Reducing Ocular Infection and Inflammation

  • Author(s)/Faculty: Jay S. Pepose, MD, PhD; Edward E. Manche, MD; Richard L. Lindstrom, MD; David R. Hardten, MD
    Source: OSN SuperSite
    Type: Monograph Articles/Items: 0
    Release Date: 5/25/2011 Expiration Date: 5/25/2012
    Credit Type: CME Number of Credit(s): 1.25
    Cost: Free Provider:
  • Endophthalmitis is a rare but serious complication of ocular surgery. This monograph will review epidemiologic studies of changing susceptibility among pathogens encountered in routine ocular care. The use of antibiotics for the prevention of postoperative infection will be evaluated, along with the use of anti-inflammatory agents for the prophylaxis of postoperative cystoid macular edema. Strategies that are effective in the treatment of endophthalmitis will also be presented.
Sponsorship Statement: This continuing education activity is jointly sponsored by Ocular Surgery News and Vindico Medical Education

Support Statement: This activity is supported by an educational grant from Bausch & Lomb

Target Audience: The intended learners for this activity are ophthalmologists and other health care professionals involved in the treatment of patients with ophthalmic disorders.

Learning Objectives:
At the conclusion of this activity, participants should be able to:
  • Analyze recent epidemiologic studies of changing susceptibility among pathogens encountered in routine ocular care and describe new anti-infective strategies for treatment.
  • Analyze recommendations from the American Society of Cataract and Refractive Surgery and the European Society of Cataract and Refractive Surgery regarding the perioperative use of antibiotic prophylaxis for the prevention of endophthalmitis.
  • Discuss the rationale for perioperative use of antibiotics and anti-inflammatories to treat the ocular surface and decrease the risk of postsurgical infection and inflammation to improve patient outcomes.
Course Chair:
Richard L. Lindstrom, MD
Chief Medical Editor
Ocular Surgery News
Editorial Board Member
Journal of Refractive Surgery and Ophthalmic Surgery Lasers & Imaging
Adjunct Professor Emeritus
University of Minnesota
Department of Ophthalmology
Founder and Attending Surgeon
Minnesota Eye Consultants, PA
Bloomington, Minnesota

Faculty:
David R. Hardten, MD
Section Editor, Cornea/External Disease
Ocular Surgery News
Associate Editor
Journal of Refractive Surgery
Adjunct Associate Professor of Ophthalmology
University of Minnesota
Partner
Minnesota Eye Consultants
Bloomington, Minnesota
 Title: Incidence and Treatment of Endophthalmitis in the Perioperative Setting: Analyzing Current Recommendations

Edward E. Manche, MD
Editorial Board Member
Journal of Refractive Surgery
Professor of Ophthalmology
Director of Cornea and Refractive Surgery
Stanford University School of Medicine
Stanford, California
 Title: Recent Epidemiologic Studies and Patient Care Strategies to Prevent Postsurgical Infection

Jay S. Pepose, MD, PhD
Editorial Board Member
Journal of Refractive Surgery
Director
Pepose Vision Institute
Professor of Clinical Ophthalmology
Washington University School of Medicine
St. Louis, Missouri
 Title: Improving Postsurgical Outcomes: Perioperative Antibiotic and Anti-infl ammatory Use

External Reviewer:
Benjamin Chacko, MD

Medical Writer:
Valerie Zimmerman, PhD

Accreditation:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ocular Surgery News® and Vindico Medical Education. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:
Vindico Medical Education designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, May 25, 2011 to May 25, 2012.

How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM certificate within 4 to 6 weeks.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Planning Committee and Faculty members report the following relationship(s):
Richard L. Lindstrom, MD

  • Consultant: Acufocus, Inc; Advanced Medical Optics; Advanced Refractive Technologies; Alcon Laboratories, Inc; Bausch + Lomb, Inc; Bio Syntrx; Bradley Scott, Inc; Calhoun Vision, Inc; Clarity Ophthalmics; Clear Sight; CoDa Therapeutics; EBV Partners; EGG Basket Ventures; Encore; Evision; Eyemaginations, Inc; Foresight Venture Fund #3; Glaukos Corporation; High Performance Optics; Improve Your Vision; I-Therapeutix; Lensar; LenSx; Lifeguard Health; Minnesota Eye Consultants, PA; NuLens; Ocular Surgery News®/SLACK®; Ocular Optics; Omega Eye Health; Omeros Corporation; Pixel Optics; Quest; Refractec; RXVP; Sight Path; Surgijet/Visijet; 3D Vision Systems; TLC Vision; Tearlabs, Inc; Tracey Technologies; Transcend Medical, Inc; True Vision; Versant; Vision Solutions Technologies
  • Investor: Acufocus, Inc; Advanced Medical Optics; Bausch + Lomb, Inc; Bio Syntrx; Bradley Scott, Inc; Calhoun Vision, Inc; Clarity Ophthalmics; Clear Sight; CoDa Therapeutics; Confluence Acquisition Partners I, Inc; EBV Partners; EGG Basket Ventures; Encore; Evision; Eyemaginations, Inc; Foresight Venture Fund #3; Fziomed; Glaukos Corporation; HEAVEN Fund; Healthcare Transaction Services; High Performance Optics; Improve Your Vision; I-Therapeutix; Lensar; LenSx; Lifeguard Health; Minnesota Eye Consultants, PA; NuLens; Ocular Optics; Omega Eye Health; Pixel Optics; Quest; Refractec; Revision Options; RXVP; Schroder Life Science Venture Fund; SightPath; Surgijet/Visijet; 3D Vision Systems; TLC Vision; Tearlabs, Inc; Tracey Technologies; Transcend Medical, Inc; True Vision; Viradax; Vision Solutions Technologies
  • Royalty: Acufocus, Inc; Bausch + Lomb, Inc; Quest
David R. Hardten, MD
  • Consultant: Abbott Medical Optics, Inc; Allergan, Inc; ESI; TLCV
  • Speakers Bureau: Abbott Medical Optics, Inc; Allergan, Inc; ESI; Inspire; ISTA Pharmaceuticals, Inc; Oculus; TLCV; Carl Zeiss Meditec
  • Research Grant Recipient: Alcon Laboratories, Inc; Allergan, Inc; Inspire; ISTA Pharmaceuticals, Inc; Peschke; Topcon
Edward E. Manche, MD
No relevant financial relationships to disclose

Jay S. Pepose, MD, PhD
  • Consultant: Abbott Medical Optics, Inc; Bausch + Lomb, Inc
  • Fees for Non-CME Services: Inspire Pharmaceuticals; TearScience
  • Ownership Interest: Acufocus, Inc; Visiometrics
External Reviewer reports the following relationship(s):
Benjamin Chacko, MD
No relevant financial relationships to disclose

Medical Writer reports the following relationship(s):
Valerie Zimmerman, PhD
No relevant financial relationships to disclose

Ocular Surgery News® and Vindico Medical Education Staff report the following relationship(s):
No relevant financial relationships to disclose

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2011 SLACK Incorporated®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Ocular Surgery News® and Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Ocular Surgery News® and Vindico Medical Education. Neither Ocular Surgery News®, Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.